Rheologics CEO Receives Prestigious Legend Award from Eastern Technology Council; Tri-States'...

Business Editors/Medical Writers

EXTON, Pa.--(BW HealthWire)--Nov. 19, 2001

Rheologics(TM) Inc. (formerly known as Visco Technologies), a pioneer in the prevention and treatment of heart disease and stroke, today announced that founder and chief executive officer, Dr. Kenneth R. Kensey, received the Eastern Technology Council's annual "Legendary CEO of the Year" Award for a lifetime of achievements and contributions. The Council serves as a networking affiliation for leaders of technology-oriented companies. Each year, the organization holds the Enterprise Awards black-tie gala at which deserving companies and individuals are honored for upholding and contributing to the vitality of the region's high-tech reputation. (The Eastern Technology Council, 9th Annual Enterprise Awards, November 15, 2001, The Pennsylvania Convention Center in Philadelphia, Pa.)

A visionary in the study of human blood flow and its relation to cardiovascular diseases like heart disease and stroke, Dr. Kensey's lifetime achievements include founding Kensey Nash Corporation (Nasdaq:KNSY) and developing many products that enhance patient well-being such as the Kensey Catheter(TM), and the AngioSeal(TM). Last week, Kensey debuted his innovative and comprehensive blood profiling methodology, the Kensey Rheolog(TM) scanning capillary viscometer, at the American Heart Association conference (American Heart Association's Scientific Sessions 2001, in Anaheim, Calif., November 11-14, 2001). The Kensey Rheolog(TM) is the first medical instrument launched by Rheologics. Dr. Kensey most recently presented at a conference sponsored by the IHS Health Group(TM), New Advances in Cardiology and Vascular Therapies (Anaheim, Calif., November 12, 2001).

"I am honored to receive this award and would like to extend the tribute to my fellow colleagues who deserve kudos for their dedication to their respective pursuits," said Ken Kensey, M.D., chairman and founder of Rheologics, Inc. "I hope that Rheologics' efforts will enable medical professionals to more effectively prevent and treat heart disease and stroke -- and ultimately save lives."

Past Award recipients include distinguished industry veterans such as Hubert Schoemaker, Ph.D. president & CEO of Neuronyx, Inc. (formerly founder, president and CEO of Centocor, Inc.); R. James Macaleer, founder of SMS Corporation (now Siemens); Al West, president & CEO of SEI Corp.; Walter Garrison, CEO of CDI Corp.; and William D. Budinger, former chairman and CEO of Rodel, Inc.

About Rheologics, Inc.

Since 1997, Rheologics Inc. (formerly known as Visco Technologies) has pioneered a new standard of care in the prevention and treatment of heart disease and stroke. Supplementing the existing understanding of the risk factors for these diseases, Rheologics' mission is to complete the picture by focusing on the emerging field of hemorheology -- the study of the dynamics of blood flow and its impact on vascular-related diseases. The company is providing the medical community with an innovative and more accurate blood viscosity measurement technology to be used at the patient point-of-care and in the development of new cardiac and stroke drug compounds. Its breakthrough product, the Kensey Rheolog(TM), is the industry's first easy-to-use viscometer for measuring the biophysical properties of unadulterated, circulating blood -- improving diagnostic research and reporting accuracy. The company is headquartered in Exton, Pa. For more information, please call 800/969-2585 or visit the company web site at www.rheologics.com.